Login Register Cart 0
Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Privileged Scaffold for Drug Design and Activity Improvement - Part V

Author(s): Yongtao Duan and Hai-liang Zhu

Volume 22, Issue 7, 2022

Published on: 02 May, 2022

Page: [549 - 549] Pages: 1

DOI: 10.2174/156802662207220503005804

« Previous Next »
[1]
Sun, M.R.; Li, H.L.; Ba, M.Y.; Cheng, W.; Zhu, H.L.; Duan, Y.T. Cyclopropyl Scaffold: A Generalist for Marketed Drugs. Mini Rev. Med. Chem., 2021, 21(2), 150-170.
[2]
Qin, J.; Cheng, W.; Duan, Y.T.; Yang, H.; Yao, Y. Indazole as a Privileged Scaffold: The Derivatives and their Therapeutic Applications. Anticancer. Agents Med. Chem., 2021, 21(7), 839-860.
[3]
Xia, L.W.; Ba, M.Y.; Liu, W.; Cheng, W.; Hu, C.P.; Zhao, Q.; Yao, Y.F.; Sun, M.R.; Duan, Y.T. Triazol: a privileged scaffold for proteolysis targeting chimeras. Future Med. Chem., 2019, 11(22), 2919-2973.
[4]
Duan, Y.; Liu, W.; Tian, L.; Mao, Y.; Song, C. Targeting Tubulin-colchicine Site for Cancer Therapy: Inhibitors, Antibody- Drug Conjugates and Degradation Agents. Curr. Top. Med. Chem., 2019, 19(15), 1289-1304.
[5]
Wang, R.; Wang, Y.A.; Xu, Y.G.; Shi, L. Privileged Scaffolds Targeting Bromodomain-containing Protein 4. Curr. Top. Med. Chem., 2022, 22(7), 600-627.
[6]
Lv, P.; Cai, Y.; Luo, J.; Chen, K. Recent advances in the design and synthesis of small molecule carbonic anhydrase IX inhibitors. Curr. Top. Med. Chem., 2022, 22(7), 550-560.
[7]
Ruan, B.-F.; Guo, Q.-L.; Li, Q.-S.; Li, L.-Z.; Deora, G.S.; Zhou, B.-G. A Review of the Biological Activities of Heterocyclic Compounds Comprising Oxadiazole Moieties. Curr. Top. Med. Chem., 2022, 22(7), 578-599.

Rights & Permissions Print Cite
Article Metrics
12
3
© 2024 Bentham Science Publishers | Privacy Policy